MRI simulation: effect of gradient distortions on three-dimensional prostate cancer plans.

PURPOSE To quantify the dosimetric consequences of external patient contour distortions produced on low-field and high-field MRIs for external beam radiation of prostate cancer. METHODS AND MATERIALS A linearity phantom consisting of a grid filled with contrast material was scanned on a spiral CT, a 0.23 T open MRI, and a 1.5 T closed bore system. Subsequently, 12 patients with prostate cancer were scanned on CT and the open MRI. A gradient distortion correction (GDC) program was used to postprocess the MRI images. Eight of the patients were also scanned on the 1.5 T MRI with integrated GDC correction. All data sets were fused according to their bony landmarks using a chamfer-matching algorithm. The prostate volume was contoured on an MRI image, irrespective of the apparent prostate location in those sets. Thus, the same target volume was planned and used for calculating the anterior-posterior (AP) and lateral separations. The number of monitor units required for treatment using a four-field conformal technique was compared. Because there are also setup variations in patient outer contours, two different CT scans from 20 different patients were fused, and the differences in AP and lateral separations were measured to obtain an estimate of the mean interfractional separation variation. RESULTS All AP separations measured on MRI were statistically indistinguishable from those on CT within the interfractional separation variations. The mean differences between CT and low-field MRI and CT and high-field MRI lateral separations were 1.6 cm and 0.7 cm, respectively, and were statistically significantly different from zero. However, after the GDC was applied to the low-field images, the difference became 0.4 +/- 0.4 mm (mean +/- standard deviation), which was statistically insignificant from the CT-to-CT variations. The mean variations in the lateral separations from the low-field images with GDC would result in a dosimetric difference of <1%, assuming an equally weighted four-field 18-MV technique for patient separations up to approximately 40 cm. CONCLUSIONS For patients with lateral separations <40 cm, a homogeneous calculation simulated using a 1.5 T MRI or a 0.23 T MRI with a gradient distortion correction will yield a monitor unit calculation indistinguishable from that generated using CT simulation.

[1]  M C Schell,et al.  MR image-guided portal verification for brain treatment field. , 1998, International journal of radiation oncology, biology, physics.

[2]  M van Herk,et al.  The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. , 1997, International journal of radiation oncology, biology, physics.

[3]  C. Langer,et al.  Concurrent chemoradiation using paclitaxel and carboplatin in locally advanced non-small cell lung cancer. , 1999, Seminars in radiation oncology.

[4]  C. Catton,et al.  Magnetic resonance imaging (MRI) for localization of the prostatic apex: comparison to computed tomography (CT) and urethrography. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  T R Willoughby,et al.  Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland. , 2000, International journal of radiation oncology, biology, physics.

[6]  M. Revenu,et al.  MRI geometric distortion: A simple approach to correcting the effects of non‐linear gradient fields , 1999, Journal of magnetic resonance imaging : JMRI.

[7]  C. Ling,et al.  Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. , 1997, International journal of radiation oncology, biology, physics.

[8]  E Bellon,et al.  The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. , 1999, International journal of radiation oncology, biology, physics.

[9]  Dennis Mah,et al.  Characteristics and quality assurance of a dedicated open 0.23 T MRI for radiation therapy simulation. , 2002, Medical physics.

[10]  M van Herk,et al.  Definition of the prostate in CT and MRI: a multi-observer study. , 1999, International journal of radiation oncology, biology, physics.

[11]  Richard Pötter,et al.  Aspects of MR Image Distortions in Radiotherapy Treatment Planning , 2001, Strahlentherapie und Onkologie.

[12]  D. Dearnaley,et al.  Magnetic resonance imaging (MRI): considerations and applications in radiotherapy treatment planning. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  J H Siewerdsen,et al.  Cone-beam computed tomography with a flat-panel imager: initial performance characterization. , 2000, Medical physics.

[14]  J Pouliot,et al.  Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. , 1997, International journal of radiation oncology, biology, physics.

[15]  C R Ramsey,et al.  Magnetic resonance imaging based digitally reconstructed radiographs, virtual simulation, and three-dimensional treatment planning for brain neoplasms. , 1998, Medical physics.

[16]  C C Ling,et al.  Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. , 2000, International journal of radiation oncology, biology, physics.

[17]  K Okajima,et al.  Development of an MR simulator: experimental verification of geometric distortion and clinical application. , 1996, Radiology.

[18]  H. Hricak,et al.  Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. , 1996, International journal of radiation oncology, biology, physics.

[19]  A. Aisen,et al.  Integration of magnetic resonance imaging into radiation therapy treatment planning: I. Technical considerations. , 1987, International journal of radiation oncology, biology, physics.

[20]  V. Khoo MRI--"magic radiotherapy imaging" for treatment planning? , 2000, The British journal of radiology.

[21]  D P Dearnaley,et al.  Comparison of MRI with CT for the radiotherapy planning of prostate cancer: a feasibility study. , 1999, The British journal of radiology.

[22]  H. Kooy,et al.  Image fusion for stereotactic radiotherapy and radiosurgery treatment planning. , 1994, International journal of radiation oncology, biology, physics.

[23]  L Verhey,et al.  Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy. , 1999, International journal of radiation oncology, biology, physics.

[24]  G E Hanks,et al.  Initial clinical assessment of CT-MRI image fusion software in localization of the prostate for 3D conformal radiation therapy. , 1997, International journal of radiation oncology, biology, physics.

[25]  S Napel,et al.  Quantifying MRI geometric distortion in tissue , 1994, Magnetic resonance in medicine.

[26]  K Okajima,et al.  Reproducibility of geometric distortion in magnetic resonance imaging based on phantom studies. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  T E Schultheiss,et al.  Ultrasound-based stereotactic guidance in prostate cancer--quantification of organ motion and set-up errors in external beam radiation therapy. , 2000, Computer aided surgery : official journal of the International Society for Computer Aided Surgery.